疾病
心肌梗塞
炎症
重症监护医学
动脉粥样硬化性心血管疾病
冲程(发动机)
临床试验
生物
医学
生物信息学
免疫学
病理
心脏病学
机械工程
工程类
作者
Peter Libby,Paul M. Ridker,Göran K. Hansson
出处
期刊:Nature
[Springer Nature]
日期:2011-05-01
卷期号:473 (7347): 317-325
被引量:3512
摘要
Atherosclerosis is a chronic disease of the arterial wall, and a leading cause of death and loss of productive life years worldwide. Research into the disease has led to many compelling hypotheses about the pathophysiology of atherosclerotic lesion formation and of complications such as myocardial infarction and stroke. Yet, despite these advances, we still lack definitive evidence to show that processes such as lipoprotein oxidation, inflammation and immunity have a crucial involvement in human atherosclerosis. Experimental atherosclerosis in animals furnishes an important research tool, but extrapolation to humans requires care. Understanding how to combine experimental and clinical science will provide further insight into atherosclerosis and could lead to new clinical applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI